Vancomycin use in pediatric hematology-oncology patients

被引：20
|
作者：
Hopkins, HA
Sinkowitz-Cochran, RL
Rudin, BA
Keyserling, HL
Jarvis, WR
机构：
[1] Ctr Dis Control & Prevent, Hosp Infect Program, Natl Ctr Infect Dis, Publ Hlth Serv,US Dept Hlth & Human Serv, Atlanta, GA 30333 USA
[2] Emory Univ, Egleston Childrens Hosp, Atlanta, GA 30322 USA
来源：
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2000年 / 21卷 / 01期
关键词：
D O I：
10.1086/501698
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
A cross-sectional study was performed of pediatric hematology-oncology patients who received vancomycin; use was compared to the Centers for Disease Control and Prevention (CDC) recommendations for vancomycin use. Thirty-seven patients received 308 doses of vancomycin. All patients initially received vancomycin as empirical therapy; 100% of this use was not consistent with the CDC recommendations (Infect Central Hosp Epidemiol 2000; 21:48-50).
引用
收藏
页码：48 / 50
页数：3
相关论文
共 50 条
  • [1] Department of pediatric hematology-oncology in Crete
    Kalmanti, M
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1996, 13 (05) : 397 - 399
  • [2] Recommendations on the use of azole antifungals in hematology-oncology patients
    Azanza, Jose Ramon
    Mensa, Jose
    Barberan, Jose
    Vazquez, Lourdes
    de Oteyza, Jaime Perez
    Kwon, Mi
    Yanez, Lucrecia
    Aguado, Jose Maria
    Gracian, Antonio Cubillo
    Solano, Carlos
    Camps, Isabel Ruiz
    Fortun, Jesus
    Lleti, Miguel Salavert
    Gudiol, Carlota
    Rubio, Teresa Olave
    Garcia-Vidal, Carolina
    Tarrats, Montserrat Rovira
    Grande, Maria Suarez-Lledo
    Gonzalez-Sierra, Pedro
    Gutierrez, Carlos Duenas
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2023, 36 (03) : 236 - 258
  • [3] INPATIENT FAMILY INTERVENTIONS WITH PEDIATRIC HEMATOLOGY-ONCOLOGY (HEMONC) PATIENTS
    Afzal, Khalid Imran
    Stiles-Shields, Colleen
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S108 - S108
  • [4] Characterics of invasive pulmonary Aspergilosis in pediatric hematology-oncology patients
    Milosevic, G. Z.
    Kovacevic, J. B.
    Lazic, J.
    Rodic, P.
    Dokmanovic, L.
    Krstovski, N.
    Arsenijevic, V. Arsic
    Janic, D.
    [J]. MYCOSES, 2017, 60 : 190 - 190
  • [5] An Outbreak of Mycobacterium mucogenicum Bacteremia in Pediatric Hematology-oncology Patients
    Shachor-Meyouhas, Yael
    Sprecher, Hannah
    Eluk, Orna
    Ben-Barak, Ayelet
    Kassis, Imad
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (01) : 30 - 32
  • [6] INPATIENT FAMILY INTERVENTIONS WITH PEDIATRIC HEMATOLOGY-ONCOLOGY (HEMONC) PATIENTS
    Afzal, Khalid Imran
    Stiles-Shields, Colleen
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S116 - S116
  • [7] Clinical use of bal galactomannan assay in high risk hematology-oncology pediatric patients
    Dokmanovic, L.
    Milosevic, G. Z.
    Krstovski, N.
    Lazic, J.
    Rodic, P.
    Janic, D.
    [J]. MYCOSES, 2017, 60 : 191 - 191
  • [8] A PC DATABASE TO FACILITATE TREATMENT OF PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS
    SCIMECA, PG
    WEINBLATT, ME
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1995, 12 (03) : 259 - 269
  • [9] EVALUATION OF AN UPDATED PEDIATRIC EARLY WARNING SCORE IN PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS
    Imperiale, Brighid
    Beuerlein, Miranda
    Graef, Jessica
    Szeles, Rose
    Mallick, Nada
    Wistinghausen, Birte
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 : S187 - S187
  • [10] Academic training pathways in pediatric hematology-oncology
    Sakamoto, Kathleen M.
    [J]. PEDIATRIC BLOOD & CANCER, 2006, 47 (03) : 239 - 241
12345